The vacuolating toxin of Helicobacter pylori mimicks the CFTR-mediated chloride conductance11Dedicated to the memory of Rossella Rolfini.  by Campello, Silvia et al.
The vacuolating toxin of Helicobacter pylori mimicks
the CFTR-mediated chloride conductance1
Silvia Campelloa, Francesco Tombolaa, Giulio Cabrinib, Mario Zorattia;
aCNR Institute of Neuroscience, Section for Biomembranes, and Department of Biomedical Sciences, University of Padova, Viale G. Colombo 3,
35121 Padua, Italy
bLaboratory of Molecular Pathology, Cystic Fibrosis Center, Piazzale Stefani 1, 37126 Verona, Italy
Received 10 September 2002; accepted 7 October 2002
First published online 14 November 2002
Edited by Maurice Montal
Abstract Cystic ¢brosis (CF) is caused by defects of the CF
transmembrane conductance regulator (CFTR), which acts both
as an anion-selective channel and as a regulator of other pro-
teins. The relative contribution of these two functions in CF
disease is debated. The toxin VacA forms channels with proper-
ties similar to those of the CFTR, and we report here that it can
insert into the membrane of various cells originating from res-
piratory epithelia, generating a chloride conductance compara-
ble to that produced by activation of the CFTR. VacA may
therefore become a valuable tool in the study of CF pathogen-
esis.
# 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: VacA; Cystic ¢brosis; Cystic ¢brosis
transmembrane conductance regulator; Chloride channel;
Respiratory epithelium; Helicobacter pylori
1. Introduction
The cystic ¢brosis (CF) transmembrane conductance regu-
lator (CFTR) is a Cl3 channel of the apical membrane of
epithelial cells, the activity of which is regulated by phosphor-
ylation and intracellular nucleotides [1]. It also functions as a
regulator of other membrane proteins, such as the Naþ-selec-
tive epithelial channel ENaC [2]. Mutations of the CF gene
can result in defective synthesis, processing and function of
CFTR [3], causing disease in various organs by incompletely
understood mechanisms.
In particular, the pathogenesis of CF lung disease, which is
characterized by recurrent infection, in£ammation and lung
destruction [1], is intriguing. Two major hypotheses have
been debated [4^8]. One view holds that in CF there is a
decrease of the depth of the airway surface liquid (ASL), while
its composition remains constant. This would interfere with
ciliary beating and movement of the mucus. The model em-
phasizes the role of the CFTR as an inhibitor of ENaC. Other
researchers have obtained data indicating that the salinity of
ASL is increased in CF. This would decrease the e¡ectiveness
of antimicrobial peptides and allow chronic colonization by
bacteria such as Pseudomonas aeruginosa. In this scheme the
major role of CFTR is considered to be in chloride conduc-
tion, i.e. as a channel. The matter of ASL salinity has proven
di⁄cult to resolve. Recent results indicate that both ASL
composition and depth are the same in normal and CF sub-
jects [9^12], and suggest that CFTR de¢ciency may impact
most on secretory gland cells [11,13]. Understanding whether
CF lung pathogenesis is linked to the role of the CFTR as a
chloride channel or as a channel regulator (or both) will be
the key to rational strategies for the treatment of CF. Indeed,
one of the therapeutic possibilities being actively explored
envisions substitution of CFTR function by activation of oth-
er endogenous chloride channels (e.g. [14^16]) or via incorpo-
ration of arti¢cial anion channels into the membrane of CF
cells (e.g. [17]).
VacA [18] is a toxin secreted by the human pathogen He-
licobacter pylori, which colonizes the mucous layer covering
the gastric mucosa and is associated with diseases such as
chronic gastritis and ulcerations [19,20]. VacA, which can be
routinely collected from culture supernatants, forms oligomer-
ic, anion-selective, slightly voltage-dependent, low-conduc-
tance channels upon insertion into arti¢cial [21^23] as well
as cell membranes, including the apical membrane of frog
gastric epithelium [24,25]. Upon internalization, these pores
alter the permeability to Cl3 of the late endosomal mem-
brane, resulting in the formation of vacuoles if permeant bases
are present. Since H. pylori generates ammonia by splitting
urea, in the stomach this phenomenon is part of the events
leading to erosion of the mucosa. If regulatory aspects are not
considered, the biophysical properties of the VacA channel
are similar to those of the CFTR: both form nearly ohmic,
anion-selective, low-conductance pores. Sensitivity to the tox-
in, measured in vacuolation assays, di¡ers markedly from cell
type to cell type [26,27], for reasons still unclear but having
mainly to do with di¡erences in binding and internalization
e⁄ciency.
The toxin thus o¡ers promise as a tool to clarify some key
mechanistic aspects of CF. As a chloride channel with a com-
pletely di¡erent structure, but comparable biophysical proper-
ties, upon insertion into the apical portion of epithelial cells it
may be expected to partly substitute for CFTR if the main
task of the latter is to conduct anions, but not if the CFTR is
mainly a regulator acting via protein^protein interactions. As
a step toward such utilization, we report here that VacA can
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indeed incorporate e⁄ciently into the membrane of various
cells obtained or derived from respiratory epithelia, and that
it can conduct chloride currents with whole-cell amplitudes in
the range of those elicited by CFTR stimulation by pharma-
cological means.
2. Materials and methods
2.1. Materials
All reagents and medium components were purchased from Sigma
(Milan, Italy) unless otherwise stated. 5-Nitro-2-(3-phenylpropylami-
no) benzoic acid (NPPB) was from Research Biochemicals Interna-
tional (Natick, MA, USA). Geneticin was from Gibco Invitrogen
S.R.L. (Milan, Italy), LHC-9 from Bio£uids (Rockville, MD, USA),
bronchial epithelial growth medium (BEGM) from Bio Whittaker
(Walkersville, MD, USA). VacA was from strain CCUG 17874, iso-
lated as previously described [28]. The toxin was activated by prein-
cubation at pH 2, 37‡C for 8 min before addition to cells.
2.2. Cells
The following human respiratory epithelial SV40-immortalized cell
lines were grown in serum-free LHC-9 medium under a 5% CO2
atmosphere: BEAS-2B, a non-CF bronchial line [29]; CFTþ/2CF
Meo3/2CFSMEo3, a tracheobronchial submucosal glandular line
from a CF patient with the vF508 mutation [30]; NFT/56FHTE8o3,
a non-CF fetal tracheal line [31]; CFT3/CFNP9o3, a nasal polyp line
from a CF patient expressing the vF508 mutation [30]. Primary cul-
tures of respiratory epithelial cells from nasal polyps and bronchial
tissue were obtained as described [32] and grown in LHC-9. The
mouse mammary epithelial C127 transformed cells stably expressing
CFTR wild-type (wt) or CFTR vF508 [33] were grown in Dulbecco’s
minimum Eagle’s medium (DMEM)+10% fetal calf serum (FCS)
(v/v) containing 200 Wg/ml geneticin. HeLa cells were grown in
DMEM plus 10% FCS, penicillin (100 U/ml) and streptomycin
(100 Wg/ml).
2.3. Vacuolation protocol
Cells were seeded, at 105 cells/ml in 12- or 24-well trays and allowed
to grow for 24 h at 37‡C. They were then rinsed and further incubat-
ed, with or without 16 nM VacA, in the following media: BEAS-2B,
CFTþ, NFT, primary bronchial cells, primary polyp cells: BEGM+5
mM NH4Cl; HeLa, CFT3, C127: minimum essential medium plus 23
mM NaHCO3, 5 mM NH4Cl, 2% FCS. The e¡ects of the toxin were
documented by photographs (Zeiss IM35 microscope; 32U objective)
approximately 4 h from the start of the incubation, after loading the
cells with neutral red as described [24].
2.4. Patch-clamp experiments
Cells were grown on glass coverslips, transferred to the patch-clamp
chamber, washed with 150 mM NaCl, 2.5 mM MgCl2, 2.5 mM CaCl2,
10 mM HEPES/Na, pH 7.3 and exposed to acid-preactivated VacA
for about 30 min at room temperature in the same medium. Whole-
cell seals were then established. The pipette solution was 110 mM
(polyp cells, Fig. 2D) or 125 mM (others) CsCl, 2 mM MgCl2,
2 mM EGTA, 10 mM HEPES/Cs, 4 mM ATP/Na, pH 7.3 (CsOH).
This composition prevented activation of volume- or Ca2þ-activated
channels, as established by control experiments in the absence of
VacA. Current conduction was recorded applying 300-ms voltage
steps from Vhold =340 mV (20-mV intervals; 15-s intervals between
pulses). For maximal stimulation of the CFTR in transfected C127
cells (Fig. 2A,B), the pipette solution was supplemented with 100 WM
cAMP (alternatively, the bath medium contained 100 WM 8-bromo-
cAMP), 100 WM 3-isobutyl-1-methylxanthine, 1 mM ATPQS and
1 U/ml protein kinase A (active subunit).
C
Fig. 1. Vacuolating e¡ects of VacA on airway epithelial cells. Left
column: controls. Right column: VacA-treated cells. Bar: 50 Wm.
A,B: HeLa cells (reference line). C,D: Nasal polyp (homozygous
CFTR vF508; primary culture). E,F: Bronchial explant (CFTR
wt; primary culture). G,H: CFTþ/2CF Meo3/2CFSMEo3 cells.
I,J: NFT/56FHTE8o3. K,L: C127 (expressing CFTR wt). VacA-
treated cells where incubated for about 4 h at 37‡C in the presence
of 16 nM toxin and 5 mM NH4Cl, while controls received only
NH4Cl. For details see Section 2.
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3. Results
VacA is known not only to discriminate between di¡erent
cell types, but also to induce vacuolation only in a cell type-,
toxin and permeant base concentration- and time-dependent
fraction of even a presumably clonal population. Also, vacu-
oles develop with di¡erent kinetics in di¡erent single cells. We
tested whether the toxin would act on airway epithelial cells,
either from primary cultures or from established immortal
lines, by visual assessment of toxin-induced vacuolation, com-
pared to that of HeLa cells in parallel experiments. Fig. 1
shows representative images. Primary cultures of human nasal
polyp cells expressing CFTR wt or homozygous CFTR
vF508, and bronchial cells (CFTR wt) vacuolated to an extent
comparable to or greater than that of HeLa cells, with a
portion of cells responding sluggishly to the toxin. The sensi-
tivity to the toxin of a few tested immortalized respiratory
epithelial cell lines varied. Two bronchial cell lines (BEAS-
2B and CFTþ) proved quite resistant, while a fetal tracheal
line (NFT) and one derived from a polyp (CFT3) were ap-
proximately as sensitive as HeLa cells. Murine C127 cells ex-
pressing CFTR wt showed a mixed behavior, as if consisting
of two distinct populations. The cells that reacted to VacA ^
approximately 60% ^ did so markedly, forming prominent
vacuoles, while the toxin had very little e¡ect on resistant
cells.
Vacuolation is believed to be a consequence of pore forma-
tion by VacA. Thus, we expected the cell lines which under-
went vacuolation to also exhibit VacA-induced currents in
whole-cell patch-clamp experiments, in analogy to the behav-
ior of HeLa cells [24]. This was indeed the case. Fig. 2
presents results from C127 (expressing CFTR wt) (A,B),
CFT3 (C) and primary culture polyp (D) cells. The whole-
cell conductance of VacA-treated cells depends on toxin con-
centration and on exposure time as well as on the cell type.
With C127 cells the results of patch-clamp experiments
could be divided into two sets: cells exhibiting no increase
of the whole-cell current level with respect to controls
(5/12), and cells showing instead a marked di¡erence (7/12;
see Fig. 2B). The presence of a sensitive and an insensitive
population agrees with the results of vacuolation experiments.
A comparison with the average I/V plot obtained under max-
imal stimulation of the CFTR (Fig. 2A) showed that intox-
ication by VacA can lead to current densities as high as or
higher than any due to the CFTR. In the case of CFT3 cells
(Fig. 2C) all VacA-exposed cells had clearly higher whole-cell
currents than the controls. This current was sensitive to the
well-known VacA inhibitor NPPB [34,35], added after the ¢rst
few rounds of recording. Primary culture polyp cells displayed
an intermediate behavior: all cells were apparently a¡ected by
VacA, but to variable extents. In Fig. 2D the data have
been arbitrarily grouped into two sets depending on whether
the current intensity measured at V=346 mV was higher or
lower than 3200 pA.
4. Discussion
The experiments presented above con¢rm that VacA can be
considered to be a ‘portable chloride channel’, capable of in-
serting into the plasma membrane of human epithelial cells,
albeit with quantitative variations depending on the cell line
and on the individual cell. The conductance increases caused
by the toxin obviously depend on the concentration applied,
and can be in the same range as those produced by CFTR
stimulation. In the absence of permeant bases, VacA induces
little cell su¡erance. Thus, it might be used to alter the per-
meability to anions of model or explanted epithelia, to verify
the e¡ect of variations of this parameter, in itself, on the
depth and composition of the super¢cial aqueous layer, mucus
production and bacterial colonization.
The selectivity of toxin action depends on incompletely
understood factors, mainly binding of the toxin to the cell
surface. In turn, di¡erences in binding characteristics are
thought to impact on membrane insertion, pore formation
and cell vacuolation. Di¡erent sensitivities by clonal cells
are tentatively ascribed to di¡erences in receptor expression.
Toxin isoform characteristics may also contribute to speci¢c-
ity [22]. Once these aspect become clearer, it might be possible
to engineer speci¢c toxin forms a¡ecting only some cell types.
The CFTR is believed to have functions in intracellular
Fig. 2. Electrophysiological behavior. Averaged I/V plots from
patch-clamp experiments in the whole-cell con¢guration. Error bars:
S.E.M. A: C127 cells transfected with the functional human CFTR
gene. Open circles: controls (no treatment; n=5); solid circles:
CFTR, maximally activated (n=8). B: Mock-transfected C127 cells.
Open squares: controls (no treatment; n=6); solid triangles: the
una¡ected subpopulation of VacA-treated cells (n=5); solid
squares: VacA-a¡ected cells (n=7). When present, VacA was 53
nM. C: CFT3 cells. Solid circles: controls (n=7); solid squares:
VacA-treated (n=7); open squares: VacA-treated after the addition
of 100 WM NPPB (n=6). When present, VacA was 16 nM. D: Na-
sal epithelial cells (primary culture of explanted polyps). Data from
wt and cf cells were pooled. Open circles: controls (n=8); solid tri-
angles: an arbitrary subset of VacA-treated cells (I346 mVs3200
pA; n=4); solid squares: the remainder of the VacA-treated cells
(n=3). When present, VacA was 10 nM.
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compartments as well as in the apical cellular membrane, and
indeed an estimated 50% is localized in intracellular compart-
ments [36]. Roles have been proposed in the regulation of
mucin expression and of membrane tra⁄c, and in the main-
tenance of a proper pH gradient across the membrane of
endosomes, secretory vesicles and the trans-Golgi network
(e.g. [36^40]). Like the CFTR, VacA has the potential to alter
pH homeostasis in intracellular compartments, both by pro-
viding an electrophoretic transport pathway for charge-bal-
ancing anions and by facilitating HCO33 di¡usion. Its action
is, however, as far as is known, restricted to the endosomal
system. A comparison between its e¡ects and those of CFTR
re-introduction in model cellular systems may therefore also
help to clarify whether alterations of the pH of some compart-
ments may or may not have an e¡ect on the chosen readout.
In summary, VacA may be a useful tool for the elucidation
of the di¡erent roles of CFTR in the pathogenesis of CF lung
disease, thanks to (a) biophysical properties similar to those of
CFTR, (b) the ability to insert into the plasma membrane of
respiratory cells and (c) its presence in the endosomal com-
partment. As more is learned about the structure^function
relationships of the toxin and its routing upon internalization,
molecular modi¢cations may become feasible which would
increase its usefulness by introducing speci¢c channel proper-
ties and targeting. The use of toxins thus ought to be consid-
ered along with gene therapy, the activation of other endog-
enous chloride channels and the exogenous administration of
chloride-conducting peptides as a possible therapeutic tool for
CF.
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